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Reply to Cordell and Farrall
To the Editor:
“…Vieland and Huang (2003) are correct in stating that,
given a set of penetrances satisfying either the Risch
(1990) or the Vieland and Huang (2003) definition of
heterogeneity, it is possible to find another set of pen-
etrances, equally compatible with the observed IBD
[identity-by-descent] sharing, that does not satisfy the
respective definition of heterogeneity.” Thus concludes
Cordell (2003 [in this issue]), and interested readers may
wish to consult the section of her text immediately fol-
lowing that statement for a recapitulation of our proof.
This means that affected sibling pairs (ASPs) cannot be
used to distinguish two-locus heterogeneity (2L HET)
from two-locus epistasis (2L EPI), as we defined these
terms, which is exactly what we claimed to have proved
in our paper (Vieland and Huang 2003). (More precisely,
this completes the proof for HET models; see Vieland
and Huang [2003] for the extension to EPI models.)
Cordell argues, however, that we would be able to
differentiate 2L HET from 2L EPI in ASP data, if we
were to change what we meant by these terms. This is
certainly true, and the literature is replete with alter-
native, often conflicting, mathematical representations
of HET and EPI. (See Cordell [2002] and Vieland and
Huang [2003] for further discussion.) So how do we
decide on our definitions in the first place?
In selecting the definition of 2L HET to be used in
Vieland and Huang (2003), we took as our primary
objective the derivation of a mathematical expression
that would capture a class of 2L models, such that any
geneticist would agree they represented locus HET in its
classical form. We therefore focused our discussion on
models with simple dominance structures—that is,
where the (marginal) mode of inheritance was either
dominant or recessive at each locus—although relaxing
this assumption, as in Risch’s (1990) definition, does not
affect our proofs. (Risch’s definition also differs from
ours in the way “phenocopies” are handled, although it
does allow for , in Vieland and Huang’s [2003]f p 0P
notation, as Cordell notes.) The resulting definition of
HET (Vieland and Huang 2003; equation 2) seems to
us impeccable, in the sense that any penetrance table
that is consistent with it is readily seen to represent the
classical concept of locus HET in terms of independent
gene action, as it applies to the known heterogeneous
Mendelian disorders. We then defined 2L EPI as any
model that did not qualify as HET, on the grounds that
either the genes act independently or they do not.
We stand by our mathematical definitions as geneti-
cally well justified and appropriate to the subject matter
of our paper. As far as we can tell, Cordell is also fun-
damentally in agreement with our definition of HET
from a genetic point of view, at least if the definition is
given in the generalized form of Risch (1990).
Cordell nevertheless proposes to adopt a different def-
inition for the purposes of reconciling the findings of
Vieland and Huang (2003) with earlier work, in which
she and her colleagues developed and applied a test for
distinguishing 2L HET (as defined by Risch) from 2L
EPI in ASPs (Cordell et al. 1995). In particular, she pro-
poses to replace the definition based on a particular
structure in the prevalence, K (as in the work of Risch
[1990] and Vieland and Huang [2003]), with a definition
based instead on K/C, where C is a constant (see Cor-
dell’s letter in the current issue for details), saying that
the models fitted in the 1995 paper “can be thought of
as implicitly using this…definition of heterogeneity on
the prevalence scale.”
The significance of this shift to a definition of 2L HET
“on the prevalence scale” is obscure in the extreme, until
one recognizes that the new definition is in essence a
simple restatement of our main result. Letting ∗f pA
, , and , Cordell’s new defini-∗ ∗f /C f p f /C f p f /CA B B AB AB
tion of HET can be written as . This∗ ∗ ∗ ∗ ∗f p f  f  f fAB A B A B
produces the requisite structure “on the prevalence
scale,” which is seen, for example, by substituting these
expressions back into the equations on p. 225 of Vieland
and Huang (2003). [We note a typographical error in
the second line of the second equation on p. 225 of
Vieland and Huang (2003), which should read as fol-
lows: .] But in terms of2 2 2 2q f  q f  q q (f  f  f )A A B B A B A B AB
the original penetrances, a little algebra shows that this
translates back to a definition of 2L HET as f pAB
). When , therefore, Cor-f  f  (1/C)(f # f Cp 1A B A B
dell’s definition and ours coincide; for any other value
of C, models conforming to her definition of HET will
satisfy neither our definition nor that of Risch. But they
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will produce identical IBD probabilities, because the
original penetrance ratios— , etc.—and the rescaledf /fA AB
penetrance ratios— , etc.—are identical (see Vieland∗ ∗f /fA AB
and Huang [2003], p. 227–228, for details).
Cordell’s new definition of HET “works” by simply
reclassifying as HET the infinitely many corresponding
EPI models, which, as Vieland and Huang (2003)
proved, cannot be distinguished from HET by their IBD
probability structure. We persist in calling these models
“EPI” because (1) they fail to qualify as HET under our
genetically based definition (or that of Risch) and (2)
because their structure precludes expression in terms of
probabilistic independence across the two loci, which
we take as the sine qua non of any reasonable definition
of HET.
The new definition thus vindicates the Cordell et al.
(1995) procedure as a statistical test. We can continue
to refer to this as a test of 2L HET versus 2L EPI if we
like, but only insofar as we are willing to consider epis-
tasis between loci as a form of HET. This is surely putting
the cart before the horse. If we wish to use statistical
modeling to learn something about real diseases, we need
to start with the genetic definitions of our terms and
then seek mathematical representations appropriate to
statistical modeling—not the other way around. This is
the only procedure for ensuring that our statistical con-
clusions have genetic relevance.
The language that Cordell and Farrall use to describe
variance-components (VC) models for dichotomous
traits additionally complicates the issue of definitions.
The fully saturated 2L VC model contains locus-specific,
or “main-effects,” terms, plus terms involving both loci,
or “interaction” terms. The saturated model is referred
to, with solid historical precedent, as Farrall (2003)
notes, as “the general epistatic…model” (Cordell 2003
[in this issue]); a test of the fit of the main-effects–only
model against the saturated model is called a test of
“whether epistatic components of variance are required
in the model” (Cordell et al. 1995).
But the main-effects model is identical to neither our
definition of 2L HET nor that of Risch. That is to say,
there are (dichotomous) 2L HET models that have these
so-called epistatic components of variance in the VC
equation. It may seem odd to say that HET models can
involve interlocus interaction terms, but nevertheless,
when the fitted VC model includes nonzero interaction
terms, one might still be looking at a HET model—that
is, a model in which the genes are acting independently
on the phenotype (Vieland and Huang 2003; Risch
1990).
A rigorous, a priori definition of HET is necessary to
systematically investigate which subclass of the saturated
VC model actually represents locus HET in the usual
genetic sense, and, indeed, this was the starting point of
our own investigation. Although we gave our proof in
terms of penetrance-based models rather than VC mod-
els, the VCs can be parameterized in terms of the more
fundamental penetrance parameters, so that the Vieland
and Huang (2003) proof applies to either framework,
as Cordell (2003 [in this issue]) makes clear. Thus, shift-
ing the discussion from penetrance-based models to VC
models has nothing to do with the mathematics of our
argument, and the language in which VC models are
described should not distract us from the underlying
issue.
Finally, we would like to address Farrall’s (2003) com-
ment that the method of Cordell et al. (1995) for dis-
tinguishing 2L HET from 2L EPI had already been “suc-
cessfully applied” to an ASP data set of patients with
insulin-dependent diabetes mellitus (IDDM). How could
the method have been successfully applied, in view of
the subsequent Vieland and Huang (2003) results?
The Cordell et al. (1995) paper actually included an
important mathematical caveat, which should have
raised a flag even at the time. Acknowledging that the
VC parameters could not all be simultaneously
(uniquely) estimated from ASP data, Cordell et al. con-
strained the maximization procedure by fixing the pop-
ulation prevalence, K, at a specific numerical value, and,
for the multiplicative model, they fixed two prevalences,
one for each locus. These ad hoc constraints solved the
numerical problem but could have distorted the relative
fit of different 2L models. (Indeed, there may be a con-
nection between this procedure and Cordell’s new def-
inition of 2L HET on the prevalence scale.) Thus, they
did not in fact succeed in completely fitting the models.
The impact of their numerical procedures on compar-
ative model fitting would need to be thoroughly inves-
tigated before we could interpret the results as telling us
something interesting about IDDM.
Their analyses were also conducted under the as-
sumption that IDDM is actually a 2L disease, an as-
sumption that is almost certainly incorrect, as they
pointed out (Cordell et al. 1995). But model fitting is
based on parameter estimation, and the behavior of es-
timates based on the assumption of 2L inheritance has
never been systematically investigated for models having
more than two loci. Cordell et al. (2000) made this point
explicitly, saying that for a complex disease, “we must
beware of overinterpretation of the estimates of the var-
iance components parameters, since…it is not clear to
what extent the parameter estimates generated under the
assumption of a two-locus—or even a three-locus—dis-
ease model will resemble their true population quanti-
ties.” This caution applies to comparative model-fitting
results based on parameter estimation as well.
Thus, the results of the application of Cordell et al.’s
(2000) methods to the IDDM data set needed all along
to be interpreted with more than a modicum of caution.
This is in no way meant to disparage the elegant math-
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ematical work in that paper, and possibly the analyses
do elucidate some interesting aspects of the data. How-
ever, the simple existence of a statistical procedure does
not, in and of itself, ensure that its application to com-
plex genetic data is appropriate or meaningful. To know
what, if anything, the results of Cordell et al. (1995)
could really have taught us about IDDM, we would need
further evaluation of the method in application to mul-
tilocus data. Appropriate definitions of HET and EPI
would need to be the starting point of any such evalu-
ation, rather than the conclusion.
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